Apax Partners-backed NuPharm Group acquired FB Health, an Italy-based speciality pharma company focused on neurology and psychiatry. Financial terms were not disclosed. "We are delighted to welcome the entire FB Health team into our Group and are looking forward to supporting its development by adding more CNS products from the sister companies to the existing business in Italy. With this acquisition and via future ones to come, we continue to move forward with our goal of becoming the Pan-European leader in the treatment of CNS diseases", said Stephan Walz, Chief Executive Officer of the Invent Farma / neuraxpharm Group (NuPharm Group).